Rotator cuff tears are a familiar frustration for shoulder surgeons. Repair the tendon perfectly, and the muscle still has the final word. Atrophy, fatty infiltration, and fibrosis can quietly undermine even technically flawless surgery, leaving the repaired cuff weaker than hoped.
A new laboratory study suggests an unexpected ally might help: blood flow restriction (BFR) therapy — and the tiny cellular power plants known as mitochondria.
According to research published in the American Journal of Sports Medicine, BFR may trigger a previously underappreciated biological process: mitochondria physically moving from one cell type to another to jump-start muscle recovery.
A Closer Look at the Biology
BFR has gained traction in lower-extremity rehabilitation, particularly after anterior cruciate ligament (ACL) reconstruction. By partially restricting blood flow during low-load exercise, therapists can stimulate muscle adaptation without heavy resistance.
But how BFR actually works at the cellular level has remained something of a mystery.
To explore the mechanism, researchers used a mouse model in which mitochondria inside fibro-adipogenic progenitor cells (FAPs) were fluorescently labeled. This allowed investigators to track whether those mitochondria moved into nearby muscle cells.
They then applied BFR to the forelimbs of healthy mice and collected supraspinatus muscle tissue over the following week.
The results were striking.
Within 24 hours of BFR treatment, mitochondria from FAP cells began appearing inside muscle fibers. The transfer continued for several days.
BFR appeared to trigger a cellular “energy donation” system — with FAP cells delivering fresh mitochondria to muscle cells that may need metabolic support.
Simulating a Massive Rotator Cuff Tear
The researchers then pushed the model further.
To simulate a severe rotator cuff injury, mice underwent supraspinatus and infraspinatus tendon transection combined with nerve injury — essentially creating a worst-case scenario for muscle degeneration.
Animals were randomized to either: BFR therapy every three days, or no BFR treatment
Muscle tissue and function were evaluated at two and six weeks. Once again, BFR stood out.
Compared with controls, mice receiving BFR showed:
- Greater mitochondrial transfer from FAP cells to muscle fibers
- Reduced muscle atrophy
- Less fatty infiltration
- Less fibrosis
- Larger muscle fiber size
But the benefits weren’t limited to the microscope slide. Functional testing revealed improved forelimb weightbearing and longer stride length in BFR-treated mice six weeks after injury.
For a model designed to mimic catastrophic cuff damage, that is a notable signal.
Why Surgeons Might Care
Rotator cuff repairs frequently fail not because the tendon repair breaks down immediately — but because muscle quality deteriorates over time. Once fatty infiltration and atrophy progress, the odds of restoring normal shoulder strength drop significantly.
If BFR truly improves muscle regeneration, it could become an intriguing addition to postoperative rehabilitation protocols. Importantly, the mechanism proposed here goes beyond simple hypertrophy.
The study suggests BFR may be activating intercellular mitochondrial transfer, a process that could restore metabolic capacity in damaged muscle.
From Mice to the Clinic
Of course, mouse shoulders are not human shoulders. Still, the study opens an interesting door. BFR is already being explored clinically in other orthopedic settings. Understanding why it works could help refine how and when it is used.
For now, the takeaway is simple: When muscles are struggling after rotator cuff injury, help may come not only from surgical repair — but from tiny power plants moving between cells.
Origin Study Title Link: Blood Flow Restriction Therapy Stimulates Intercellular Mitochondria Transfer and Improves Muscle Regeneration and Shoulder Function in a Murine Rotator Cuff Injury Model
Authors: Nesa Milan, MD, Aboubacar Wague, BA, Luke Sang, BS, Alex Youn, BA, Ryan Sadjadi, MPhil, Yusef Samimi, BA, Cristhian Montenegro, PhD, Miguel Lizarraga, BS, Justin Lau, BS, Allan I. Basbaum, PhD, Michael R. Davies, MD, Hubert T. Kim, MD, PhD, Brian T. Feeley, MD, Jarret A.P. Weinrich, PhD, Xuhui Liu, MD